Literature DB >> 28193660

Antimicrobial Resistance of Escherichia coli Urinary Isolates in the Veterans Affairs Health Care System.

Haley J Morrill1,2,3, Jacob B Morton4,3, Aisling R Caffrey4,2,3, Lan Jiang2, David Dosa2,5, Leonard A Mermel2,6,7, Kerry L LaPlante4,2,3,7.   

Abstract

We reviewed data for almost 300,000 clinical Escherichia coli urinary isolates (collected in 2009 through 2013) from 127 inpatient and outpatient facilities, to assess antibiotic resistance among Veterans Affairs health care system patients using Clinical and Laboratory Standards Institute and Centers for Disease Control and Prevention National Healthcare Safety Network definitions or guidance. Rates of resistance to amoxicillin or ampicillin/β-lactamase inhibitors were approximately 40% and rates of resistance to fluoroquinolones and trimethoprim-sulfamethoxazole approached 30%. Rates of resistance to nitrofurantoin, antipseudomonal penicillin/β-lactamase inhibitors, and carbapenems remained less than 10%. The percentage of isolates that were considered multidrug resistant varied (4% to 37%), depending on the definitions used.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Escherichia coli; resistance; urinary tract infection

Mesh:

Substances:

Year:  2017        PMID: 28193660      PMCID: PMC5404570          DOI: 10.1128/AAC.02236-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  Surveillance of antimicrobial resistance--what, how and whither?

Authors:  R Bax; R Bywater; G Cornaglia; H Goossens; P Hunter; V Isham; V Jarlier; R Jones; I Phillips; D Sahm; S Senn; M Struelens; D Taylor; A White
Journal:  Clin Microbiol Infect       Date:  2001-06       Impact factor: 8.067

Review 2.  Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute.

Authors:  Janet F Hindler; John Stelling
Journal:  Clin Infect Dis       Date:  2007-02-08       Impact factor: 9.079

3.  Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections.

Authors:  S K Fridkin; J R Edwards; F C Tenover; R P Gaynes; J E McGowan
Journal:  Clin Infect Dis       Date:  2001-06-21       Impact factor: 9.079

Review 4.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

5.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

6.  Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region?

Authors:  Monique R Bidell; Melissa Palchak; John Mohr; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

7.  Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America.

Authors:  Thomas M Hooton; Suzanne F Bradley; Diana D Cardenas; Richard Colgan; Suzanne E Geerlings; James C Rice; Sanjay Saint; Anthony J Schaeffer; Paul A Tambayh; Peter Tenke; Lindsay E Nicolle
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

8.  In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010.

Authors:  Guillermo V Sanchez; Ronald N Master; James A Karlowsky; Jose M Bordon
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

9.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014.

Authors:  Lindsey M Weiner; Amy K Webb; Brandi Limbago; Margaret A Dudeck; Jean Patel; Alexander J Kallen; Jonathan R Edwards; Dawn M Sievert
Journal:  Infect Control Hosp Epidemiol       Date:  2016-08-30       Impact factor: 3.254

10.  Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012.

Authors:  Guillermo V Sanchez; Ahmed Babiker; Ronald N Master; Tony Luu; Anisha Mathur; Jose Bordon
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

View more
  14 in total

1.  Geographic Mapping of Escherichia coli Susceptibility To Develop a Novel Clinical Decision Support Tool.

Authors:  Laurel Legenza; Susanne Barnett; James P Lacy; Codie See; Natalee Desotell; Andrea Eibergen; Jeffrey F Piccirillo; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states.

Authors:  Edward Goldstein; Derek R MacFadden; Zeynal Karaca; Claudia A Steiner; Cecile Viboud; Marc Lipsitch
Journal:  Int J Antimicrob Agents       Date:  2019-03-06       Impact factor: 5.283

Review 3.  MarR family proteins are important regulators of clinically relevant antibiotic resistance.

Authors:  Grace A Beggs; Richard G Brennan; Mehreen Arshad
Journal:  Protein Sci       Date:  2019-11-14       Impact factor: 6.725

Review 4.  Antimicrobial resistance in nephrology.

Authors:  Tina Z Wang; Rosy Priya L Kodiyanplakkal; David P Calfee
Journal:  Nat Rev Nephrol       Date:  2019-08       Impact factor: 28.314

5.  Top Questions in Uncomplicated, Non-Staphylococcus aureus Bacteremia.

Authors:  Jesse D Sutton; Sena Sayood; Emily S Spivak
Journal:  Open Forum Infect Dis       Date:  2018-04-21       Impact factor: 3.835

6.  Levels of outpatient prescribing for four major antibiotic classes and rates of septicemia hospitalization in adults in different US states - a statistical analysis.

Authors:  Edward Goldstein; Scott W Olesen; Zeynal Karaca; Claudia A Steiner; Cecile Viboud; Marc Lipsitch
Journal:  BMC Public Health       Date:  2019-08-19       Impact factor: 3.295

7.  Sociodemographic Inequalities in Urinary Tract Infection in 2 Large California Health Systems.

Authors:  Joan A Casey; Kara E Rudolph; Sarah C Robinson; Katia Bruxvoort; Eva Raphael; Vennis Hong; Alice Pressman; Rachel Morello-Frosch; Rong X Wei; Sara Y Tartof
Journal:  Open Forum Infect Dis       Date:  2021-05-26       Impact factor: 3.835

8.  Stopping the effective non-fluoroquinolone antibiotics at day 7 vs continuing until day 14 in adults with acute pyelonephritis requiring hospitalization: A randomized non-inferiority trial.

Authors:  Pavankumar Rudrabhatla; Surendran Deepanjali; Jharna Mandal; Rathinam Palamalai Swaminathan; Tamilarasu Kadhiravan
Journal:  PLoS One       Date:  2018-05-16       Impact factor: 3.240

Review 9.  Antibiotic Resistance Among Uropathogenic Escherichia coli.

Authors:  Barbara Kot
Journal:  Pol J Microbiol       Date:  2019-12-05

10.  Poor clinical outcomes associated with suboptimal antibiotic treatment among older long-term care facility residents with urinary tract infection: a retrospective cohort study.

Authors:  Haley J Appaneal; Theresa I Shireman; Vrishali V Lopes; Vincent Mor; David M Dosa; Kerry L LaPlante; Aisling R Caffrey
Journal:  BMC Geriatr       Date:  2021-07-23       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.